Introduction
============

Infertility has been reported in 50%--70% of patients with unilateral testicular tumors, of whom 15% exhibit azoospermia \[[@B1]\]. Fertility-preserving treatment of these patients is important, particularly before adjuvant chemotherapy, since testicular tumors often develop in males younger than 5 years of age or those who are in their 20s and 30s \[[@B2]\]. Similarly, bilateral testicular cancer patients and testicular cancer patients with a solitary testis due to a previous contralateral orchiectomy become infertile due to the orchiectomy technique itself. Therefore, fertility preservation prior to surgery is important in these patients. Herein, we report the case of a testicular tumor in the solitary testis of a patient who had previously undergone successful contralateral orchiectomy and whose spermatozoa were preserved using radical inguinal orchiectomy and simultaneous onco-testicular sperm extraction (onco-TESE).

Case report
===========

A 35-year-old man complaining of right scrotum enlargement visited the urology department at a nearby hospital. He had a history of left orchiectomy during childhood although the cause was unknown. His wife was 26 years old and had no gynecological abnormality. During his visit, he was diagnosed with a right testicular tumor, and was expected to undergo left orchiectomy at the same hospital. Before surgery, the patient visited Reproduction Center of Yokohama City University Medical Center for sperm cryopreservation. Written informed consent was obtained for research purposes at the initial visit. The right scrotum was swollen to the size of a chicken egg without pain. A laboratory examination showed almost normal levels of lactate dehydrogenase, α-fetoprotein, and β-human chorionic gonadotropin. His testosterone level was low (1.96 ng/mL). Ultrasonography indicated that most of the testis exhibited a mosaic echoic pattern. However, normal testicular tissue was palpated along the edge of the testis ([Figure 1](#F1){ref-type="fig"}). Semen analysis revealed azoospermia, and no spermatozoa were observed in the pellet after centrifugal separation. After discussions with the referring hospital, semi-emergency left radical inguinal orchiectomy and onco-TESE were performed simultaneously at our reproductive medicine center. Although most of the testicular space was occupied by the tumor, a small amount of normal seminiferous tubules was detected and extracted macroscopically ([Figure 2](#F2){ref-type="fig"}). *Ex vivo* sperm extraction under a microscope during bench surgery was performed from the extracted specimen. Motile spermatozoa were detected and approximately 15,600 spermatozoa were obtained. They were divided into 10 vials for cryopreservation. Pathological analysis of the tumor lesion revealed many atypical cells with clear cell bodies and conspicuous nucleoli, thereby indicating a typical seminoma. The diagnosis was pure seminoma, pT1N0M0. Normal spermatogenesis was confirmed in a portion of the normal tissue and the mean Johnsen score count was 8.3 ([Figure 3](#F3){ref-type="fig"}). There was no tumor recurrence at a 6-month follow-up visit, and the patient currently receives ongoing testosterone supplementation due to depressed testosterone levels after surgery.

Discussion
==========

Over the past decade, the treatment of patients with testicular cancer has improved dramatically with the development of anticancer drugs, including platinum formulations \[[@B3]\]. Yet, as the number of young cancer survivors continues to increase, there must be a concomitant improvement of the quality of the life of these patients \[[@B4]\]. Furthermore, fertility preservation among adolescent and young adult patients is critical, with gonadotropic therapy being a critical form of treatment. If spermatozoa viability is confirmed prior to cancer therapy, cryopreservation of semen should always be recommended before performing treatment that can result in infertility, such as radiotherapy, chemotherapy, or surgery \[[@B5]\]. Furthermore, onco-TESE should be considered for patients whose semen analysis indicates azoospermia.

Onco-TESE is a procedure that allows spermatozoa to be obtained from the normal testis of patients who do not emit sperm prior to cancer therapy \[[@B6]\]. Onco-TESE can be used in patients with azoospermia, severe oligozoospermia, or an ejaculation disorder before chemotherapy, as well as in patients with a single testis whose fertility would be damaged by testicular cancer treatment.

To our knowledge, there have been reports of only 44 patients, including our patient, who have undergone onco-TESE \[[@B6][@B7][@B8][@B9][@B10]\]. In these reports, spermatozoa were successfully preserved in only 23 cases (52.2%). Moreover, only six cases of onco-TESE, including this case, have been reported in patients with a single testis after unilateral orchiectomy ([Table 1](#T1){ref-type="table"}). In five of the six cases, sperm retrieval was successful. Descombe et al. \[[@B10]\] reported a live twin birth after intracytoplasmic sperm injection using sperm retrieved by onco-TESE. Previous studies have reported an inverse correlation between tumor size and the presence of spermatogenesis, with 81%--86% and 57% of patients with a tumor size of 1--2 cm and 5 cm, respectively, exhibiting healthy spermatozoa production \[[@B11]\]. Similarly, Suzuki et al. \[[@B12]\] showed a negative correlation between the Johnsen score count and the maximum diameter of the tumor. They further found that spermatogenesis improved in cases with a greater distance between the seminiferous tubules and the tumor. Compared with the other previous five cases of onco-TESE in patients with a single testis, the tumor in our patient was the largest. In addition, while there was extensive normal testicular tissue apart from the tumor lesion in the other five cases, the tumor cells occupied most of the testis in our case, and very little normal tissue was confirmed. This is the first report of successful onco-TESE from a single testis occupied by a large tumor with very few normal seminiferous tubules. Although we first speculated that, given our initial findings, testicular sperm extraction would be difficult, we were able to retrieve and store spermatozoa successfully. In cases such as the one presented herein, the surgeon should attempt to identify healthy seminiferous tubules within the tumor tissue. Further study of such cases and the associated fertility outcomes should be conducted.

In conclusion, we experienced a case of azoospermia in a patient with a large testicular tumor in a single testis. We successfully performed sperm retrieval through onco-TESE. This is the first report of successful onco-TESE from a single testis occupied by a large tumor with very few normal seminiferous tubules. In such cases, it is important to search for normal tissue within the testicle.
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![Ultrasonography of the right testis. Normal testicular tissue was palpated along the edge of the testis (arrow).](cerm-45-44-g001){#F1}

![Formalin-fixed specimen extracted from the right testis. Although most of the testis was occupied by the tumor, a small amount of normal seminiferous tubules was detected (arrow).](cerm-45-44-g002){#F2}

![Pathological analysis of the normal testicular tissue. Normal spermatogenesis was confirmed in some seminal tubules (black arrows). The mean Johnsen score count was 8.3.](cerm-45-44-g003){#F3}

###### Previous cases of patients with testicular cancer who underwent orchiectomy and onco-TESE in a single testis
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